Pharmacokinetic Aspects of Digoxin-Specific Fab Therapy in the Management of Digitalis Toxicity
- 1 June 1995
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 28 (6) , 483-493
- https://doi.org/10.2165/00003088-199528060-00006
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Determination of Free Serum Digoxin Concentrations in Digoxin Toxic Patients After Administration of Digoxin Fab AntibodiesTherapeutic Drug Monitoring, 1992
- Clinical and Pharmacokinetic Profiles of Digoxin Immune Fab in Four Patients with Renal ImpairmentDICP, 1991
- Retreatment with digoxin immune Fab.1991
- Monitoring Serum Digoxin Concentrations during Digoxin Immune Fab TherapyDICP, 1991
- Treatment of Digoxin Intoxication in a Renal Failure Patient with Digoxin-Specific Antibody Fragments and PlasmapheresisAmerican Journal of Nephrology, 1990
- Effects of Digoxin Immune Fab (ovine) on Digoxin ImmunoassaysAmerican Journal of Clinical Pathology, 1989
- Determination of free digoxin concentrations in serum for monitoring Fab treatment of digoxin overdose.Clinical Chemistry, 1987
- Digoxin-like immunoreactivity eliminated from serum by centrifugal ultrafiltration before fluorescence polarization immunoassay of digoxin.Clinical Chemistry, 1987
- Treatment of 63 severely digitalis-toxic patients with digoxin-specific antibody fragmentsJournal of the American College of Cardiology, 1985
- Reversal of Advanced Digoxin Intoxication with Fab Fragments of Digoxin-Specific AntibodiesNew England Journal of Medicine, 1976